Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bis{?-2-[1-(pyridin-2-yl-methyl-imino)-eth-yl]phenolato}bis-(azido-zinc).

ABSTRACT: The title compound, [Zn(2)(C(14)H(13)N(2)O)(2)(N(3))(2)], is a phenolate-bridged centrosymmetric dinuclear zinc(II) complex. The Zn?Zn distance is 3.076?(1)?Å. Each Zn atom is five-coordinated by two O and two N atoms from two Schiff base ligands, and by one azide N atom, forming a square-pyramidal geometry.

SUBMITTER: Miao JY

PROVIDER: S-EPMC3247522 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Bis{μ-2-[1-(pyridin-2-yl-methyl-imino)-eth-yl]phenolato}bis-(azido-zinc).

Miao Jian-Ying JY

Acta crystallographica. Section E, Structure reports online 20111029 Pt 11

The title compound, [Zn(2)(C(14)H(13)N(2)O)(2)(N(3))(2)], is a phenolate-bridged centrosymmetric dinuclear zinc(II) complex. The Zn⋯Zn distance is 3.076 (1) Å. Each Zn atom is five-coordinated by two O and two N atoms from two Schiff base ligands, and by one azide N atom, forming a square-pyramidal geometry. ...[more]

PMID: 22219827

Similar Datasets

Bis{μ-2-[2-(2-pyrid-yl)ethyl-imino-meth-yl]phenolato}bis-[azido-zinc(II)].

Project description:In the centrosymmetric title dinuclear zinc(II) compound, [Zn(2)(C(14)H(13)N(2)O)(2)(N(3))(2)], each Zn(II) ion has a slightly distorted trigonal bipyramidal geometry and is coordinated by two N atoms and one O atom from one Schiff base ligand, an O atom from the other Schiff base ligand, and another N atom from an azide ligand. The crystal structure involves inter-molecular C-H⋯N hydrogen bonds.

| S-EPMC2961521 | biostudies-literature

(μ-4-Bromo-2-{1-[2-(dimethyl-amino)ethyl-imino]eth-yl}phenolato)bis-[ethyl-zinc(II)].

Project description:The title complex, [Zn(2)(C(2)H(5))(2)(C(12)H(16)BrN(2)O)(2)], is dimeric, bridged through the O atoms of the phenolate anions. The molecule lies on a crystallographic twofold rotation axis. Each Zn atom is penta-coordinated by two N atoms and two bridging O atoms of the tridentate salicylideneiminate ligands and one C atom from an ethyl group, forming a distorted square-pyramidal environment.

| S-EPMC2915078 | biostudies-literature

Di-?(1,1)-azido-bis-[(2-{1-[2-(isopropyl-amino)ethyl-imino]eth-yl}phenolato)copper(II)].

Project description:In the centrosymmetric binuclear title complex, [Cu(2)(C(13)H(19)N(2)O)(2)(N(3))(2)], the Cu(II) atom adopts an elongated CuON(4) square-based pyramidal coordination geometry, arising from the N,N',O-tridentate ligand and two bridging end-on azide anions. The O atom is in the basal plane, one of the azide N atoms is in the apical site and the Cu?Cu separation is 3.2365?(3)?Å. A pair of intra-molecular N-H?O hydrogen bonds helps to establish the mol-ecular conformation.

| S-EPMC2979365 | biostudies-literature

Bis{2-eth-oxy-6-[2-(methyl-ammonio)ethyl-imino-meth-yl]phenolato}thio-cyanato-zinc(II) nitrate.

Project description:In the title compound, [Zn(NCS)(C(12)H(18)N(2)O(2))(2)]NO(3), the Zn(II) ion is chelated by the phenolate O and imine N atoms from two zwitterionic Schiff base ligands and is also coordinated by the N atom of a thio-cyanate ligand, giving a distorted trigonal-bipyramidal geometry. Intra-molecular N-H?O hydrogen bonds are observed in the complex cation. The nitrate anions are linked to the complex cations through N-H?O hydrogen bonds.

| S-EPMC2979686 | biostudies-literature

Bis{?-2-[(pyridin-2-yl)imino-meth-yl]phenolato}bis-[(2-formyl-phenolato)copper(II)].

Project description:The asymmetric unit of the title compound, [Cu(2)(C(12)H(9)N(2)O)(2)(C(7)H(5)O(2))(2)], contains two independent (2-formyl-phen-olato){2-[(pyridin-2-yl)imino-meth-yl]phenolato}copper(II) mol-ecules that form pseudocentrosymmetric dimers via inter-actions between the Cu and pyridyl N atoms of independent monomers. The square-planar geometry of the Cu atoms in the monomer thus becomes square-based pyramidal in the dimer. The crystal studied was an inversion twin, with unequal populations of 0.353?(17) and 0.647?(17).

| S-EPMC3120375 | biostudies-literature

Bis{?-2-[1-(2-Pyridylmethyl-imino)eth-yl]phenolato}bis-[azido-copper(II)].

Project description:The title compound, [Cu(2)(C(14)H(13)N(2)O)(2)(N(3))(2)], was synthesized by the reaction of Cu(NO(3))(2)·3H(2)O with the Schiff base 2-[1-(2-pyridylmethyl-imino)eth-yl]phenol (HL) in methanol-water solution, adding NaN(3) as the bridging ligand. The asymmetric unit contains one half-mol-ecule, the other half being generated by the inversion center. Each Cu(II) atom shows a slightly distorted trigonal-pyramidal geometry formed by two N atoms and one O atom from one Schiff base ligand, by another O atom of a second Schiff base ligand and by an azide N atom. The crystal structure is stabilized by intermolecular C-H?N hydrogen bonds.

| S-EPMC2970141 | biostudies-other

Bis(2-meth-oxy-6-{[2-(methyl-ammonio)eth-yl]imino-meth-yl}phenolato)thio-cyanato-zinc(II) thio-cyanate hemihydrate.

Project description:The title mononuclear zinc(II) complex, [Zn(C(11)H(16)N(2)O(2))(2)(NCS)]NCS·0.5H(2)O, consists of a complex cation, a thio-cyanate anion, and half of a water mol-ecule. The Zn(II) atom in the cation is five-coordinated by two imine N and two phenolate O atoms from two bidentate Schiff base ligands, and by one N atom of a thio-cyanate ligand, forming a distorted trigonal-bipyramidal geometry. The ammonio H atoms are involved in hydrogen bonding with the ligand O atoms and the solvent water molecules (site occupation factor 0.5), which partially determines the conformation of the ligands.

| S-EPMC2969465 | biostudies-literature

Bis{2-[(1H-pyrrol-2-yl)methyl-imino-meth-yl]phenolato-κN,O}zinc(II).

Project description:In the title compound, [Zn(C(12)H(11)N(2)O)(2)], the Zn(II) atom, lying on an inversion center, is coordinated by two O atoms and two N atoms from two salicylal Schiff base ligands in a distorted square-planar geometry. A three-dimensional network is formed by inter-molecular C-H⋯N hydrogen bonds and C-H⋯π contacts.

| S-EPMC2969913 | biostudies-literature

Bis{2-[1-(benzyl-imino)-eth-yl]phenolato}palladium(II).

Project description:In the title compound, [Pd(C(15)H(14)NO)(2)], the Pd atom lies on an inversion center and is coordinated by two ligand mol-ecules through the O and N atoms in a bidentate manner, forming a slightly distorted square-planar geometry. The dihedral angle between the two benzene rings in the ligand is 76.53 (19)°. The mol-ecular packing is stablized by C-H⋯O and C-H⋯π inter-actions.

| S-EPMC3007840 | biostudies-literature

Bis{?-2-meth-oxy-6-[(methyl-imino)-meth-yl]phenolato}bis-({2-meth-oxy-6-[(methyl-imino)-meth-yl]phenolato}copper(II)).

Project description:The title compound, [Cu2(C9H10NO2)4], is built of discrete centrosymmetric dimers. The Cu(II) atoms are each five coordinated by two deprotonated Schiff base ligands that are bonded differently to the metal atoms. Of the two phenolate O atoms, one is coordinated to one Cu(II) atom, whereas another bridges the two metal atoms. The basal plane of the square pyramid around Cu(II) atoms is formed by the imino N and phenolate O atoms of the bidentate and the monodentate/bidentate Schiff base ligands. The bridging phenolate oxygen occupies the apical position of the coordination sphere with a considerably longer Cu-O bond length. In the crystal, the dimeric mol-ecules pack relative to each other in such a way that the Cu2O2 planes of adjacent dimers are orthogonal.

| S-EPMC3790358 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data